Therapy of osteoporosis in patients with Crohn's disease: a randomized study comparing sodium fluoride and ibandronate.

@article{Tirpitz2003TherapyOO,
  title={Therapy of osteoporosis in patients with Crohn's disease: a randomized study comparing sodium fluoride and ibandronate.},
  author={Christian von Tirpitz and Jochen Klaus and Martin Steinkamp and Lorenz Christian Hofbauer and Wolfgang Kratzer and R. E. A. Mason and B O Boehm and Guido Adler and Max Reinshagen},
  journal={Alimentary pharmacology & therapeutics},
  year={2003},
  volume={17 6},
  pages={807-16}
}
BACKGROUND Osteoporosis is a frequent complication in Crohn's disease. Although the efficacy of both sodium fluoride and aminobisphosphonates in postmenopausal osteoporosis has been investigated in long-term therapy studies, no long-term results are available regarding the effect of these agents in the management of osteoporosis in patients with Crohn's disease. METHODS Eighty-four patients with Crohn's disease and pathological bone mineral density findings were randomized to receive either… CONTINUE READING